This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Astarie-Dequeker, C.
Right arrow Articles by Maridonneau-Parini, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Astarie-Dequeker, C.
Right arrow Articles by Maridonneau-Parini, I.

 Previous Article  |  Next Article 

Infection and Immunity, August 2000, p. 4827-4830, Vol. 68, No. 8
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Lipoarabinomannans Activate the Protein Tyrosine Kinase Hck in Human Neutrophils

Catherine Astarie-Dequeker, Jérôme Nigou, Germain Puzo, and Isabelle Maridonneau-Parini*

Institut de Pharmacologie et de Biologie Structurale, CNRS UPR 9062, 31077 Toulouse, France

Received 18 October 1999/Returned for modification 27 December 1999/Accepted 5 April 2000

The mycobacterial lipoarabinomannans (LAMs) are glycosylphosphatidyl-myo-inositol-anchored lipoglycans with diverse biological activities. It has been shown that purified LAMs interact directly, or indirectly, through receptors with the plasma membrane receptors of target cells located in domains rich in glycosylphosphatidylinositol-anchored proteins that contain Src family protein tyrosine kinases. To examine whether LAMs could activate Src-related kinases, human neutrophils were exposed to mannosylated LAMs (ManLAMs) purified from the vaccinal strain Mycobacterium bovis BCG and to phosphoinositol-capped LAMs (AraLAM or PILAM) obtained from the nonpathogenic species Mycobacterium smegmatis. We report first that both ManLAMs and PILAMs activate Hck in a rapid and transient manner and second that complete deacylation of ManLAM abolished its effect on Hck activity, thereby demonstrating that acylation of LAM but not mannosylation is critical for Hck activation. These data indicate that Hck is involved in the signaling pathway of LAMs, molecules known for their ability to trigger several responses in eukaryotic cells.


* Corresponding author. Mailing address: Institut de Pharmacologie et de Biologie Structurale, CNRS UPR 9062, 205 Route de Narboune, 31077 Toulouse, France. Phone: 33 561 54 58. Fax: 33 561 59 94. E-mail: maridono{at}ipbs.fr.


Infection and Immunity, August 2000, p. 4827-4830, Vol. 68, No. 8
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Yan, S. R., Byers, D. M., Bortolussi, R. (2004). Role of Protein Tyrosine Kinase p53/56lyn in Diminished Lipopolysaccharide Priming of Formylmethionylleucyl- phenylalanine-Induced Superoxide Production in Human Newborn Neutrophils. Infect. Immun. 72: 6455-6462 [Abstract] [Full Text]  
  • Vazifeh, D., Abdelghaffar, H., Labro, M. T. (2002). Effect of Telithromycin (HMR 3647) on Polymorphonuclear Neutrophil Killing of Staphylococcus aureus in Comparison with Roxithromycin. Antimicrob. Agents Chemother. 46: 1364-1374 [Abstract] [Full Text]  
  • Carreno, S., Gouze, M.-E., Schaak, S., Emorine, L. J., Maridonneau-Parini, I. (2000). Lack of Palmitoylation Redirects p59Hck from the Plasma Membrane to p61Hck-positive Lysosomes. J. Biol. Chem. 275: 36223-36229 [Abstract] [Full Text]